Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 381

1.

Endocrine Society of Australia position statement on male hypogonadism (part 2): treatment and therapeutic considerations.

Yeap BB, Grossmann M, McLachlan RI, Handelsman DJ, Wittert GA, Conway AJ, Stuckey BG, Lording DW, Allan CA, Zajac JD, Burger HG.

Med J Aust. 2016 Sep 5;205(5):228-31.

PMID:
27581270
2.

Endocrine Society of Australia position statement on male hypogonadism (part 1): assessment and indications for testosterone therapy.

Yeap BB, Grossmann M, McLachlan RI, Handelsman DJ, Wittert GA, Conway AJ, Stuckey BG, Lording DW, Allan CA, Zajac JD, Burger HG.

Med J Aust. 2016 Aug 15;205(4):173-8.

PMID:
27510348
3.

Risks and benefits of hormone therapy: has medical dogma now been overturned?

Shapiro S, de Villiers TJ, Pines A, Sturdee DW, Baber RJ, Panay N, Stevenson JC, Mueck AO, Burger HG.

Climacteric. 2014 Jun;17(3):215-22. doi: 10.3109/13697137.2014.905529. Epub 2014 Apr 23.

PMID:
24654673
4.

Competency in menopause management: whither goest the internist?

Santen RJ, Stuenkel CA, Burger HG, Manson JE.

J Womens Health (Larchmt). 2014 Apr;23(4):281-5. doi: 10.1089/jwh.2014.4746. Epub 2014 Mar 13. Review.

PMID:
24625303
5.

Re: Estrogen plus progestin and breast cancer incidence and mortality in the women's health initiative observational study.

Shapiro S, deVilliers TJ, Pines A, Sturdee DW, Archer DF, Baber RJ, Panay N, Farmer RD, Stevenson JC, Mueck AO, Burger HG, Gompel A.

J Natl Cancer Inst. 2014 Feb;106(2):djt372. doi: 10.1093/jnci/djt372. Epub 2013 Dec 22. No abstract available.

PMID:
24363446
6.

The perimenopausal woman: endocrinology and management.

Hale GE, Robertson DM, Burger HG.

J Steroid Biochem Mol Biol. 2014 Jul;142:121-31. doi: 10.1016/j.jsbmb.2013.08.015. Epub 2013 Oct 14. Review.

PMID:
24134950
7.

Conduct of the Women's Health Initiative randomised trial evaluating estrogen plus progestin: implications for breast cancer findings: authors' response.

Shapiro S, Farmer RD, Stevenson JC, Burger HG, Mueck AO, Gompel A.

J Fam Plann Reprod Health Care. 2013 Jul;39(3):228-9. doi: 10.1136/jfprhc-2013-100673. No abstract available.

8.

The stages of reproductive aging as proposed by workshops held in 2001 and 2010 (STRAW and STRAW + 10): a commentary.

Burger HG.

Climacteric. 2013 Aug;16 Suppl 1:5-7. doi: 10.3109/13697137.2013.798769. Epub 2013 May 9. No abstract available.

PMID:
23627358
9.

Does hormone replacement therapy (HRT) cause breast cancer? An application of causal principles to three studies.

Shapiro S, Farmer RD, Stevenson JC, Burger HG, Mueck AO, Gompel A.

J Fam Plann Reprod Health Care. 2013 Apr;39(2):80-8. doi: 10.1136/jfprhc-2012-100508.

10.

Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials.

van Die MD, Burger HG, Teede HJ, Bone KM.

Planta Med. 2013 May;79(7):562-75. doi: 10.1055/s-0032-1327831. Epub 2012 Nov 7. Review.

11.

Evidence-based assessment of the impact of the WHI on women's health.

Burger HG, MacLennan AH, Huang KE, Castelo-Branco C.

Climacteric. 2012 Jun;15(3):281-7. doi: 10.3109/13697137.2012.655564. Review.

PMID:
22612616
12.

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies. Part 4: the Million Women Study.

Shapiro S, Farmer RD, Stevenson JC, Burger HG, Mueck AO.

J Fam Plann Reprod Health Care. 2012 Apr;38(2):102-9. doi: 10.1136/jfprhc-2011-100229. Epub 2012 Jan 16.

13.

Unpredictable endocrinology of the menopause transition: clinical, diagnostic and management implications.

Burger HG.

Menopause Int. 2011 Dec;17(4):153-4. doi: 10.1258/mi.2011.011026. Epub 2011 Nov 25.

PMID:
22120939
14.

A randomized study of the effect of mifepristone alone or in conjunction with ethinyl estradiol on ovarian function in women using the etonogestrel-releasing subdermal implant, Implanon®.

Weisberg E, Croxatto HB, Findlay JK, Burger HG, Fraser IS.

Contraception. 2011 Dec;84(6):600-8. doi: 10.1016/j.contraception.2011.04.008. Epub 2011 Jun 8.

PMID:
22078189
15.

Changes in serum antim├╝llerian hormone levels across the ovulatory menstrual cycle in late reproductive age.

Robertson DM, Hale GE, Fraser IS, Hughes CL, Burger HG.

Menopause. 2011 May;18(5):521-4. doi: 10.1097/gme.0b013e3181f8d9e0.

PMID:
21178792
16.

Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Santen RJ, Allred DC, Ardoin SP, Archer DF, Boyd N, Braunstein GD, Burger HG, Colditz GA, Davis SR, Gambacciani M, Gower BA, Henderson VW, Jarjour WN, Karas RH, Kleerekoper M, Lobo RA, Manson JE, Marsden J, Martin KA, Martin L, Pinkerton JV, Rubinow DR, Teede H, Thiboutot DM, Utian WH; Endocrine Society.

J Clin Endocrinol Metab. 2010 Jul;95(7 Suppl 1):s1-s66. doi: 10.1210/jc.2009-2509. Epub 2010 Jun 21. Review.

17.

Effects of a combination of Hypericum perforatum and Vitex agnus-castus on PMS-like symptoms in late-perimenopausal women: findings from a subpopulation analysis.

van Die MD, Bone KM, Burger HG, Reece JE, Teede HJ.

J Altern Complement Med. 2009 Sep;15(9):1045-8. doi: 10.1089/acm.2008.0539.

PMID:
19757982
18.

Vitex agnus-castus (Chaste-Tree/Berry) in the treatment of menopause-related complaints.

van Die MD, Burger HG, Teede HJ, Bone KM.

J Altern Complement Med. 2009 Aug;15(8):853-62. doi: 10.1089/acm.2008.0447. Review.

PMID:
19678775
19.

Predictors of placebo response in a randomized, controlled trial of phytotherapy in menopause.

van Die MD, Teede HJ, Bone KM, Reece JE, Burger HG.

Menopause. 2009 Jul-Aug;16(4):792-6. doi: 10.1097/GME.0b013e318199d5e6.

PMID:
19587583
20.

Are we drawing the right conclusions from randomised placebo-controlled trials? A post-hoc analysis of data from a randomised controlled trial.

van Die MD, Bone KM, Burger HG, Teede HJ.

BMC Med Res Methodol. 2009 Jun 23;9:41. doi: 10.1186/1471-2288-9-41.

Supplemental Content

Loading ...
Support Center